Skip to main content

Table 2 Top 20 proteins found to be significantly altered in rosiglitazone-treated cells compared with DMSO-treated cells

From: Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells

Protein names

Peptides

Sequence coverage (%)

Molecular weight (kDa)

Fold changes

P values

Acsl1

33

55.8

78.0

149.3

1.1E−04

CD36

12

32.4

52.7

64.4

0.037

FABP4

8

56.1

14.7

39.9

2.8E−04

Pcx

33

36.4

129.8

18.7

5.1E−06

Lpl

12

32.5

53.1

9.6

0.003

Col15a1

12

10.9

140.5

8.0

6.4E−05

Acox1

13

30.4

74.6

7.9

6.5E−06

FABP5

7

57

15.1

7.7

0.015

Aldh6a1

9

26.2

57.9

6.7

7.2E−05

Mgst1

3

17.9

25.8

6.3

0.002

Emilin1

21

34.9

107.6

0.06

4.6E−05

Abcb1b

1

8.9

141.0

0.09

8.7E−04

Dpysl3

17

45.1

73.9

0.11

5.8E−05

IL1RN

7

70.4

18.0

0.11

2.1E−04

Fibronectin

3

49.3

262.8

0.18

5.8E−05

Col12a1

14

7.3

340.2

0.20

0.020

Wls

4

7

62.2

0.20

1.2E−04

Cnn3

10

45.5

36.4

0.23

3.5E−05

Lmcd1

10

34.8

41.0

0.25

0.002

Rai14

11

16.2

108.9

0.25

0.007